Data Snapshot: Nov 02, 2026
$1M+

Oct-2026

Sales

Decline

Trend

6-Month

77

Product Count

SKUs

$29.3

Avg Price

-32.6%

YoY Sales Change

2.1%

YoY Price Change

MTL Cannabis is a Montreal-based, privately owned entity and parent company of Abba Medix Corp. and Montréal Medical Cannabis Inc., known for their localized dedication to modernizing street cannabis culture. Operating from a spacious 57,000 sq ft licensed facility with potential for extension, the brand is recognized as one of Canada's rapidly growing dried flower consumer brands since its recreational market debut in October 2020.
How loyal are cannabis customers to the brands they buy? See retention benchmarks by category and state →
For brands

Is this your brand?

See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.

See your brand's data
For retailers

Carry this brand in your store?

Headset Retailer is free. Connect your POS and see what's selling and what's sitting.

Sign up free
MTL Cannabis Sales

Market Insights Snapshot

MTL Cannabis Historical Sales by Category

MTL Cannabis concentrated over four-fifths of October 2026 sales in inhalables, with Flower at 50.25% share and Pre-Roll at 32.75%, while Concentrates held 14.89% and Vapor Pens 2.12%. Year over year, Flower declined 38.95% and Pre-Roll fell 33.58%, yet Concentrates contracted only 10.76%; month over month, Flower dropped 11.16% and Pre-Roll slid 11.83% but Concentrates rose 8.34%. The average price moved up 2.14% versus last year even as total brand sales decreased 32.56% YoY, and in Ontario the mix remains anchored by Flower. The pattern implies a demand shift within the portfolio away from Flower and toward Concentrates, with shrinking MoM volumes in the two largest categories putting pressure on overall rank position, as suggested by a Flower rank of 25 in Saskatchewan.

The pivot signal is that Concentrates are gaining relative weight despite overall declines: a 14.89% share paired with an 8.34% MoM increase contrasts with double‑digit MoM contractions in Flower (‑11.16%) and Pre-Roll (‑11.83%). With average price up 2.14% YoY against a 32.56% YoY sales decline and a 24‑month sales erosion of 69.52%, the mix suggests price resilience but volume leakage in core inhalables. The thesis is that maintaining Flower at roughly half of sales while it declines faster than the portfolio creates a drag on positioning, and the improving Concentrates trajectory offers the clearest avenue to stabilize rank in Flower-led provinces like Ontario by redistributing emphasis toward formats showing positive MoM momentum.

Oct-2026 Rank
Flower
Pre-Roll
Concentrates
Vapor Pens
#70
#93
—
—
#44
#62
—
—
#27
#56
#8
—
#25
#27
—
—
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Flower
50.2%
$49.40
-39.0%
-11.2%
Pre-Roll
32.7%
$17.84
-33.6%
-11.8%
Concentrates
14.9%
$29.08
-10.8%
+8.3%
Vapor Pens
2.1%
$43.84
—
-7.0%
MTL Cannabis

Competitive Landscape

MTL Cannabis is ranked #27 in ON Flower in October 2026, down 7 positions year over year from #20 and 8 positions lower than three months ago from #19; this sits well below its peak of #11 reached in October 2024, indicating a two-year slide in placement. In contrast, Back Forty / Back 40 Cannabis climbed from #2 to #1 while growing sales 17.4% year over year, and Shred moved from #3 to #2 with 26.7% YoY sales growth, whereas Pure Sunfarms held at #5 with a -14.1% YoY sales decline, highlighting that MTL Cannabis’s rank loss is occurring amid both advancing leaders and weakened incumbents. The pattern implies MTL Cannabis’s trajectory is tied less to category contraction and more to relative share erosion versus ascending value players, and without a reversal of the 7-rank YoY drop and 8-rank quarter-over-quarter slide, further displacement from the top 20 is likely.

MTL Cannabis category ranking vs. nearest competitors
MTL Cannabis

Notable Products

MTL Cannabis’s October 2026 lineup is concentrated, with the top 10 items accounting for 66.3% of sales and Sage N' Sour Pre-Roll 3-Pack (1.5g) alone at 11.5%. New launches barely register at 0.9% of sales, so most of its sales ride on established products.

Product
Type
Share of Sales
Avg Price
vs. Peer Avg
MoM %
Sage N' Sour Pre-Roll 3-Pack (1.5g)
Hybrid - Single Strain
11.5%
$17.28
+15.9%
+0.3%
Sage n' Sour Hash (2g)
Hash
9.2%
$29.35
+6.5%
+12.6%
Sage N Sour (3.5g)
Sativa
9.2%
$29.38
+15.4%
+10.5%
Wes' Coast Kush (14g)
Hybrid
6.8%
$81.22
+8.7%
-16.9%
West Coast Kush (3.5g)
Hybrid
5.8%
$29.29
+19.7%
-5.6%
Sage N Sour (28g)
Sativa
5.8%
$140.78
+42.4%
-29.4%
Wes' Coast Kush Hash (2g)
Hash
5.7%
$28.65
+3.5%
+2.1%
Strawberry N' Mintz Pre-Roll 3-Pack (1.5g)
Sativa - Single Strain
5.2%
$16.42
+22.1%
-10.3%
Sage n' Sour Pre-Roll 10-Pack (5g)
Hybrid - Single Strain
3.8%
$38.39
+29.9%
+1.7%
Jungl' Cake (14g)
Hybrid
3.4%
$81.93
+9.6%
-3.7%

Peer avg: average price of the same product type and package size in the same states that month.

View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market